PRT-6286

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePRT-6286
Drug Alias Nameanti-inflammatory/anti-metastatic compound (Proteologics)ubiquitin ligase inhibitor (Proteologics)ubiquitin ligase inhibitor (Proteologics/Teva)selective ligase inhibitor (Proteologics)PRT-6286
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin-protein ligases inhibitors
TargetsUbiquitin-protein ligases
Therapy Area/IndicationsInflammationNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProteologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProteologics IncTeva Pharmaceutical Industries Ltd
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A